Dr. Berkenblit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
35 Cambridgepark Dr
Cambridge, MA 02140Phone+1 617-665-7796
Education & Training
Harvard Medical SchoolClass of 1996
Certifications & Licensure
MA State Medical License 1998 - 2026
Clinical Trials
- Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia Start of enrollment: 2016 Mar 01
Publications & Presentations
PubMed
- 52 citationsA6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer : A phase I trialAnna Berkenblit, Ursula A. Matulonis, Joan Kroener, Bruce J. Dezube, Gil N. Lam
Gynecologic Oncology. 2005-10-01 - 78 citationsCharacterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion s...Lainie P. Martin, Jason A. Konner, Kathleen N. Moore, Shelly Seward, Ursula A. Matulonis
Gynecologic Oncology. 2017-11-01 - 103 citationsPhase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma.Birgit Geoerger, Mark W. Kieran, Stephan A. Grupp, Danuta Perek, Jill S. Clancy
European Journal of Cancer. 2012-01-01
Press Mentions
Oncolytics Biotech® Doses First Patient in Study of Pelareorep/FOLFIRINOX Combination Therapy in Pancreatic CancerJune 20th, 2024- ImmunoGen Announces Clinical Collaboration with Gilead to Evaluate Pivekimab Sunirine in Combination with Magrolimab in Relapsed/Refractory Acute Myeloid LeukemiaDecember 9th, 2022
- ImmunoGen Needs to Make the Most of Its First-Mover OpportunityNovember 30th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
